Related Experiment Video
Updated: Jul 3, 2026
10:22
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Genotype Complexity Modulates Antimalarial Susceptibility in vitro.
Chinedu Ogbonnia Egwu1,2, Olusola Ajibaye1,3, Fatoumata Bojang1
1Disease Control and Elimination, Medical Research Council Unit, Banjul, The Gambia.
Infection and Drug Resistance
|July 2, 2026
Summary
Resistant Plasmodium falciparum strains drive antimalarial drug response, even in mixed infections. Continuous surveillance is crucial to combat malaria drug resistance.
Area of Science:
- Malariology
- Parasitology
- Drug Resistance Studies
Background:
- Antimalarial drug resistance in Plasmodium falciparum is a major obstacle to malaria control.
- The impact of mixed infections (multiple parasite strains) on antimalarial drug efficacy is not fully understood.
Purpose of the Study:
- To investigate how mixed infections of drug-resistant and susceptible Plasmodium falciparum strains affect antimalarial drug efficacy.
- To assess the role of parasite strain complexity in treatment outcomes.
Main Methods:
- Used Gambian field isolates and laboratory strains (Dd2, 3D7) for complexity assays.
- Determined parasite survival and reinvasion rates using IC50 and malaria drug survival assays (mDSA) after exposure to chloroquine (CQ), piperaquine (PPQ), dihydroartemisinin (DHA), and lumefantrine (LUM).
- Analyzed complexity of infection (COI) using McCOIL and exposed co-cultured lab strains to CQ, DHA, and LUM at varying proportions.
Main Results:
- Resistant parasite haplotypes in mixed infections significantly influence drug response, shifting the IC50 values.
- This IC50 shift was most pronounced for chloroquine when using mixed 3D7/Dd2 strains.
- Field isolates showed high parasite reinvasion rates after sub-therapeutic drug exposure, with chloroquine-resistant strains surviving better even in mixtures.
Conclusions:
- Antimalarial drug responses under pressure are predominantly driven by circulating resistant Plasmodium falciparum haplotypes.
- The presence of resistant strains significantly impacts treatment effectiveness, even when mixed with susceptible strains.
- Continuous surveillance for drug resistance is essential for effective malaria control strategies.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...